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The multidomain zinc endopeptidase matrix
metalloproteinase-9 (MMP-9) is a recognized
therapeutic target in autoimmune diseases,
vascular pathologies, and cancer. Despite its
importance, structural characterization of full-
length pro-MMP-9 is incomplete. Here, we report
the structural model of full-length pro-MMP-9
and, in particular, the molecular character of its
unique proline-rich and heavily O-glycosylated
(OG) domain. Using a powerful combination of
small-angle X-ray scattering and single-mole-
cule imaging, we demonstrate that pro-MMP-9
possesses an elongated structure with two
terminal globular domains connected by an un-
structured OG domain. Image analysis high-
lights the flexibility of the OG domain, implicating
its role in the varied enzyme conformations and
in facilitating independent movements of the
terminal domains. This may endorse recognition,
binding, and processing of substrates, ligands,
as well as receptors and marks this domain as
an additional target for the design of selective
regulators.INTRODUCTION
The physiological and pathological roles ofmatrixmetallo-
proteinases (MMPs) are versatile. Members of the MMP
family have been implicated in numerous aspects of the
migration of inflammatory and cancer cells through con-
nective tissues, not only by catabolizing extracellular ma-
trix (ECM) components, but also by processing various
soluble mediators, promoting many disease states (Ste-
tler-Stevenson et al., 1993; Werb and Chin, 1998; Wolf
et al., 2003). Although all MMPs share similar catalyticStructure 15, 1227–123sites (Maskos, 2005), marked differences are observed
in their substrate specificity, due, at least in part, to the
presence of additional substrate-binding sites in noncata-
lytic protein domains. As a consequence, different MMPs
have different biological functions. MMP-9, also known as
gelatinase B, is a prototypical target in inflammatory
diseases, because of its tissue-damaging roles (Agrawal
et al., 2006; Liu et al., 1998; Opdenakker et al., 2003;
Van den Steen et al., 2004) and inflammation-promoting
processing of soluble proteins, including protease inhibi-
tors (Liu et al., 2000), chemokines (Van den Steen et al.,
2000), and cytokines (Heissig et al., 2002; Nelissen et al.,
2003; Yu and Stamenkovic, 2000).
In contrast, MMP-2, or gelatinase A, mainly has anti-in-
flammatory and homeostatic functions, and it presumably
acts by inactivating inflammatory chemokines (McQuib-
ban et al., 2000) and by regulating connective tissue
turn-over (Monaco et al., 2006). This functional dichotomy
between both enzymes has clearly been demonstrated in
several knockout studies (Garg et al., 2006; Itoh et al.,
2002). It also implies that selective inhibitors, discriminat-
ing between these highly similar enzymes, are crucial for
efficient anti-inflammatory therapy without side effects
(Hu et al., 2007). From this perspective, other noncatalytic
parts of the enzyme, differentiating MMP-2 and MMP-9,
may be targeted to generate selective inhibitors.
Interestingly, the main structural difference between
MMP-9 and MMP-2 is the presence of an extensively
O-glycosylated (OG) domain in MMP-9 (Opdenakker
et al., 2001; Van den Steen et al., 2006). Other domains
in MMP-9 are also found in MMP-2 and include a pro-
peptide domain responsible for maintaining latency; a
catalytic domain in which three fibronectin repeats are
inserted; and a C-terminal domain, also known as the
hemopexin domain, that constitutes an exosite for bind-
ing of the endogenous MMP-9 inhibitor, tissue inhibitor
of metalloproteinase 1 (TIMP-1) (Piccard et al., 2007; Wil-
helm et al., 1989). Despite its great importance in many
disease states and in contrast to MMP-2 (Morgunova
et al., 1999), the available structural information about6, October 2007 ª2007 Elsevier Ltd All rights reserved 1227
Figure 1. Characterization of Pro-
MMP-9
(A) Crystal structures of the terminal domains.
The N-terminal domain of pro-MMP-9 (PDB
code: 1L6J) is comprised of the propeptide
(green), three fibronectin type-II repeats
(blue), and a catalytic domain (red) with the
zinc-containing active site (gray sphere). The
OG domain (dashed line) contains a 64 residue
fragment of unknown structure, and it con-
nects the N-terminal domain to the C-terminal
hemopexin domain (PDB code: 1ITV), which
consists of four propeller blades (cyan).
(B) Size-exclusion chromatography shows the
elution profile of oligomeric species (peak 1,
15.8 min; peak 2, 22.7 min) and monomeric
(peak 3, 25.1 min) forms of pro-MMP-9. Inset:
Porath plot (Siegel and Monty, 1966) of protein
standards with known Stokes radii were used
to calibrate the superdex 200 column (from
right to left: thyroglobulin, 85 A˚; ferritin, 61 A˚;
catalase, 52.2 A˚; aldolase, 48.1 A˚; albumin,
35.5 A˚). The cubic root of Kd is plotted against
the Stokes radius of each protein, and the lin-
ear least-square fit is shown.
(C) Glycerol sedimentation was applied in
order to separate monomers from higher
oligomeric structures in preperative amounts.
Aliquots from each fraction were assayed in a gelatin zymogram. High oligomeric structures are present in fractions 1–3. Fraction 3 contained a mix-
ture of all oligomeric forms. Fractions 4–7 mostly contained the monomeric form.
(D) Analytical ultracentrifugation sedimentation velocity analysis was used to calculate the distribution of the sedimentation coefficient. Inset: mod-
eling the sedimentation profiles (lines) from the experimental data (dots) as a function of time and distance from the axis of rotation. A residuals plot is
shown in the upper panel. For clarity, only every tenth profile used in the analysis is shown.
Structure
Structural Model of Full-Length Pro-MMP-9MMP-9 is limited to its two terminal domains, rather than
the full-length enzyme. The X-ray structure of the N-termi-
nal part (Elkins et al., 2002), containing the procatalytic
domain, shows that it possesses a matrixin fold (Stocker
and Bode, 1995). The C-terminal hemopexin domain con-
sists of a four-bladed b propeller structure with pseudo
four-fold symmetry (Cha et al., 2002). Figure 1A presents
the crystal structures of the procatalytic and the hemo-
pexin domains of pro-MMP-9. The domains are con-
nected by a dotted line representing the 64 amino acid
linker (containing 22 proline residues, 6 glycine
residues, and 12–14 O-linked glycans [Van den Steen
et al., 2001]). Importantly, the OG domain of pro-MMP-9
is 2–3 times longer than analogous regions of collage-
nases, stromelysins, and gelatinase A, of the MMP family,
for which typical linker lengths span a range of only 21–27
amino acid residues.
Crystallization of the OG domain in pro-MMP-9 sepa-
rately or together with other protein domains has been
proven difficult. The lack of a large side chain in the
case of glycine and the presence of a built-in bend in
the case of proline interfere with the formation of second-
ary structure and often result in loops or unstructured
regions. In addition, the presence of clustered serines
and threonines as attachment points for O-glycans might
yield steric effects that could hinder crystallographic
packing. This domain has also been termed the collagen
V-like domain, due to its sequence similarity to collagen1228 Structure 15, 1227–1236, October 2007 ª2007 Elsevier LtdV (Wilhelm et al., 1989), and has recently been renamed
the OG domain (Van den Steen et al., 2006). The OG do-
main is active in the orientation of the hemopexin do-
mains to enable exosite interactions. However, nothing
is known of the influence of the OG domain on the overall
three-dimensional structure of MMP-9 and its biophysi-
cal nature.
Here, we report on a powerful structural analysis
combining small-angle X-ray scattering (SAXS) with sin-
gle-molecule atomic force microscopy (AFM) imaging to
characterize a full-length structural model of pro-MMP-9
and the molecular character of its OG linker domain.
SAXS followed by image and structural reconstruction
analyses provided the molecular shape of full-length
pro-MMP-9, which represents the sum of all possible con-
formations in solution. This structural model, which is sup-
ported by high-resolution AFM imaging and biophysical
measurements, shows an elongated protein with the OG
domain acting as a flexible 30 A˚ long linker between the
two terminal domains. The degree of flexibility of the OG
domain is statistically evaluated from the various protein
conformations detected by single-molecule imaging. This
provides insights into the role of protein domain flexibility
in the regulation of recognition, binding, and processing of
substrates, ligands, and receptors required for MMP-9
activities. This suggests that blocking such domain flexi-
bility by antagonists may constitute a way of regulating
the pathological activities of this enzyme.All rights reserved
Structure
Structural Model of Full-Length Pro-MMP-9RESULTS AND DISCUSSION
Molecular size and shape determination, structural
reconstruction, and analysis of single-molecule images of
pro-MMP-9 monomers require monodispersed and homo-
geneous protein samples. We have therefore combined
various methods to express, isolate, and characterize
the monomeric form of pro-MMP-9.
Isolation and Characterization of Pro-MMP-9 in Its
Monomeric Form
Recombinant pro-MMP-9 was expressed and purified
from baculovirus-infected Sf9 cells as previously reported
(Van den Steen et al., 2006) (see Experimental Proce-
dures). This enzyme forms mixtures of monomers and
other higher oligomeric species (Wilhelm et al., 1989). Di-
mers of MMP-9 are detected under physiological condi-
tions (Olson et al., 2000). These dimers are resistant to dis-
sociation by SDS, are sensitive to chemical reduction, and
require the presence of the OG domain to be formed. The
monomeric form of MMP-9 is stable, and no dynamic
equilibrium between the monomer and higher oligomeric
states are observed (Van den Steen et al., 2006). In this
work, we have focused on the structural characterization
of the monomeric form of pro-MMP-9.
Figure 1B shows the relative molecular ratio of pro-
MMP-9monomer to its oligomeric species, as determined
by analytical size-exclusion chromatography (SEC). The
main peak (No. 3) in the chromatogram comprises the
pro-MMP-9 monomer with a Stokes radius of 45.4 A˚
(see inset). The Stokes radius was determined based on
the corresponding retention time by using conventional
procedures (see the Supplemental Data available with
this article online).
Isolation of pro-MMP-9 monomers from higher oligo-
meric species in preparative amounts was achieved by
glycerol-gradient sedimentation (Olson et al., 2000).
Figure 1C shows zymography analysis of the various frac-
tions (see the Supplemental Data). The isolated monomer
fraction was subjected to analytical ultracentrifugation
(AUC) for additional estimation of its Stokes radius (Fig-
ure 1D). In this sedimentation velocity experiment, a uni-
form pro-MMP-9 solution is subjected to a gravimetric
field. This produces a depletion of solute near the menis-
cus and the formation of a sharp boundary between the
depleted region and the sedimenting solute (which is of
uniformconcentration) (Figure 1D, inset). The rate ofmove-
ment of this boundary can be measured and leads to
the determination of the sedimentation coefficients, which
depends directly on the mass of the particles and in-
versely on the frictional ratio, which is, in turn, a measure
of effective size and shape (see the Supplemental Data).
The pro-MMP-9 monomer was found to sediment as
a single species, with the main peak representing 91%
of the total protein in the sample, with a normalized sedi-
mentation coefficient, s20,w, of 4.4 S (Figure 1D). This
value is compatible with a recent measurement (Van den
Steen et al., 2006). A Stokes radius of 44.1 A˚ was com-
puted with the program SEDNTERP (Laue et al., 1992)Structure 15, 1227–123by using a calculated partial specific volume of 0.7328
cm3/g (see the Supplemental Data). Calculation of themo-
lar mass of pro-MMP-9 (see the Supplemental Data and
Figure S1) based on the AUC data suggests that this pro-
tein is monomeric in solution. AUC-based shape analysis
(by using the experimental frictional ratio) indicated that
pro-MMP-9 would be hydrodynamically equivalent to
a prolate ellipsoid with an estimated axial ratio of 1:6.
The molecular radial results obtained by AUC are consis-
tent with the value obtained by SEC (45.4 A˚). In addition,
theoretical estimation of the radius by applying SEDN-
TERP and using the pro-MMP-9 molar mass and amino
acid and glycan composition yielded a molecular equiva-
lent, spherical radius of 28.7 A˚. Deviation of this value from
the experimental Stokes radii provides another indication
for a nonspherical shape—one that is either elongated or
distorted.
Molecular Shape Analysis of Pro-MMP-9 by
Small-Angle X-Ray Scattering Reveals an
Elongated Three-Domain Structure
The global conformation of the pro-MMP-9 monomer in
solution was investigated by using SAXS. This method uti-
lizes the elastic scattering of incident X-ray photons by the
target molecule electrons. The electron density distribu-
tion, as governed by the arrangement of atoms in the mol-
ecule, leads to an interference pattern. The three-dimen-
sional shape of the molecule is then reconstructed from
the scattering profile (Svergun and Koch, 2002).
Scattered intensity was observed over a momentum
transfer range of 0.008 < q < 0.46 A˚1 (q = 4psinq/l) cor-
responding to a d-spacing range of 14 < r < 785 A˚. The
lower value (14 A˚) presents the approximate, qualitative
nature of the resolution value for the obtained measure-
ments. The scattered intensities are linear in the small-q
region (for a scattering profile, see Figure 2A) and are
nicely fitted by the Guinier law. The slope was found to
be weakly correlated with protein concentration. This
means that neither aggregation nor interparticle interfer-
ence contributes significantly to the signal. In addition,
we have used the forward scattered intensity analysis to
calculate the molar mass of pro-MMP-9 (Mylonas and
Svergun, 2007). For this, we have used a protein standard
with a knownmolecular weight. The details of this analysis
are described in the Supplemental Data. In agreement
with the AUC result, the SAXS data indicate that pro-
MMP-9 retains its monomeric form in solution. The radius
of gyration (Rg) resulting from the measurement is 50 ± 2.7
A˚. The function p(r) represents the distribution of inter-
atomic distances within the molecule (pair distribution
function; Figure 2A, inset). Extraction of Rg from p(r) gives
a comparable value, 49.2 A˚, indicating accurate prelimi-
nary data analysis (prior to the fitting procedure). Themax-
imal interatomic distance (Dmax) is 160 A˚. The shape of p(r)
is indicative of an elongated ellipsoid structure (see, for
example, Receveur et al., 2002; Violot et al., 2005; von
Ossowski et al., 2005).
The three-dimensional reconstruction model of pro-
MMP-9 was obtained by using the programs GASBOR6, October 2007 ª2007 Elsevier Ltd All rights reserved 1229
Figure 2. Structural Analysis of Pro-MMP-9
(A) SAXS data of pro-MMP-9 in solution. Experimental X-ray intensity data (black dots) are compared with the most probable model (gray line) by
using CHADD. Inset: pair distribution function of the experimental SAXS data.
(B) Pro-MMP-9 models reconstructed by using CHADD. The models obtained from the SAXS data are represented by gray spheres with a radius of 5
A˚. Each model was rotated at 0 and 90 along the vertical axis. The docked crystal structures of the N- and C-terminal domains (Cha et al., 2002;
Elkins et al., 2002) are represented as blue and red ribbons, respectively.
(C) Prediction of a long-disorder region (thick, black line), by using PONDR (Li et al., 1999), in the sequence of pro-MMP-9 and the corresponding
domain organization (top bar: PRO, propeptide; CAT+FN, catalytic domain and three fibronectin type-II repeats; OG, O-glycosylated domain;
PEX, hemopexin domain).
(D) Fitting of the calculated scattering curve of the full-length pro-MMP-9 with the reconstructed OG domain to the experimental data. The calculated
curves of the best three models are shown as green, cyan, and yellow lines. The experimental data are represented as black dots. The three best
models of the OG domain were calculated by using RAPPER (DePristo et al., 2003a, 2003b) within the CHADD model.
(E) Structural reconstruction of the OG domain. The best three models are shown in ribbon representation and are colored green, cyan, and yellow.
Structure
Structural Model of Full-Length Pro-MMP-9(Svergun et al., 2001) andCHADD (Petoukhov et al., 2002).
Theoretical scattering curves are simulated from three-di-
mensional arrangements of spherical centers (or dummy
residues) representing protein residues, which combine
to form the overall protein shape. The final protein shape
is determined by iterative fitting of the simulated theoreti-
cal curves to the experimental data. The advantage of
CHADD is in the use of a priori knowledge obtained from
available crystal structure of isolated domains to introduce
constraints in the data analysis procedures. In contrast,
models produced by GASBOR are calculated without1230 Structure 15, 1227–1236, October 2007 ª2007 Elsevier Ltdany a priori knowledge. For clarity, here we report the
best model obtained by CHADD (a detailed comparison
is described in the Supplemental Data and Figure S2).
Figure 2B shows the three-dimensional reconstructed
structural model of pro-MMP-9. The Stokes radius of the
reconstructed structure of pro-MMP-9 was calculated
by using the program HYDROPRO (Garcia De La Torre
et al., 2000). This calculated radius ranges between 44.9
and 47.1 A˚, which agrees with the measured values of
45.4 and 44.1 A˚ obtained by SEC and AUC, respectively.
Furthermore, both the SAXS model and the axial ratioAll rights reserved
Structure
Structural Model of Full-Length Pro-MMP-9parameter obtained by AUC suggest an elongated shape.
Hence, the reconstructed shape restored from the exper-
imental SAXS profile is consistent with the measured
hydrodynamic data obtained both by SEC and AUC.
The simulated curve-fitting analysis of this structural
model is presented in Figure 2A (gray curve). The location
of the alpha carbon backbone of the procatalytic domain
was used as a constraint in the structural reconstruction
analysis, while the OG and the hemopexin domains were
reconstructed by using CHADD. Finally, the crystal struc-
tures of the procatalytic (Elkins et al., 2002) domain and
the hemopexin domain (Cha et al., 2002) were sequentially
docked to the contour density by using the software SUP-
COMB (Kozin and Svergun, 2001) (Figure 2B). The remain-
ing density belongs to the OG domain that separates the
two terminal domains by 30 A˚. This value was further
verified by calculating the theoretical p(r) curves based
on the crystal structures of the isolated N-terminal and
C-terminal domains by using the software CRYSOL (Sver-
gun et al., 1995). The calculated Dmax values for these do-
mains are 80 A˚ and 50 A˚, respectively. Subtracting these
values from the experimental Dmax of full-length pro-
MMP-9 (160 A˚) provides further verification of the recon-
structed structure in which the terminal domains are
separated by 30 A˚.
Inspecting the volumes occupied by the OG and hemo-
pexin domains reveals that they are of similar volume.
However, the calculatedmolarmass of theOGdomain, in-
cluding the O-glycans, is about half that of the hemopexin
domain. Computational sequence analysis of the OG do-
main by using PONDR (Li et al., 1999) revealed that this
region is significantly disordered relative to the other do-
mains (Figure 2C). Thus, despite its observed compact
conformation, this proline-rich OG domain possesses
a disordered structure of relatively low density. Therefore,
the relatively bulky electron density of the OG domain, de-
tected by SAXS, represents the sum of the scattering con-
tribution of the different conformations retained by the OG
domain in solution. This suggests that the OG domain is
flexible. We have used the structural modeling program
RAPPER (DePristo et al., 2003a, 2003b) to model possible
linker conformations that will fit the observed scattering
profile and density map. Specifically, 8 out of 500 calcu-
lated conformers fit the SAXSmodel of the linker. Theoret-
ical scattering curves were calculated (by using the SAXS
program CRYSOL [Svergun et al., 1995]) for the overall
pro-MMP-9 model structure. Figures 2D and 2E describe
the best linker models that fit both the experimental scat-
tering curve and the SAXS density map of pro-MMP-9.
The OG linker appears to exhibit multiple putative, un-
structured conformations.
Characterization of Shape and Domain Flexibility
of Pro-MMP-9 by Single-Molecule Imaging
To further verify our SAXS analysis, we have designed an
experiment to directly visualize the shape of pro-MMP-9,
as predicted in Figures 2B and 2E, and to evaluate themo-
lecular properties of its OG domain. Specifically, we con-
ducted single-molecule imaging analysis of wild-type andStructure 15, 1227–123of an OG-deleted mutant of pro-MMP-9 (pro-MMP-
9DOG) by using AFM. Reproducible images of single
pro-MMP-9 molecules (Figure 3) were obtained by cross-
linking the protein samples to an amine-modified silanized
layer on a Si(111) surface prior to AFM imaging (see Ex-
perimental Procedures and the Supplemental Data for
details).
Samples were imaged both under buffer solution and in
air (see the Supplemental Data and Figure S4). The best
images were obtained in semidry mode with a ‘‘spike’’
tip. Figures 3A–3C show a single-molecule image of wild-
type pro-MMP-9 immobilized on the modified Si(111)
surface. Consistent with the reported SAXS analysis, the
protein image possesses an elongated multidomain
structure. The image cross-section (Figure 3C) represent-
ing height versus width reveals two separate protein
domains presumably connected by the OG linker. In con-
trast, the pro-MMP-9DOG mutant lacking the 64 residue
OG domain exhibits a rather spherical shape with unre-
solved domain separation (Figures 3D–3F).
Single-Molecule Imaging Statistical Analysis
Coupled with SAXS Reveals Protein Domain
Flexibility Mediated by the OG Domain
A striking feature contrasting the wild-type pro-MMP-9
and the mutant pro-MMP-9DOG is that the spread in
both width and height values for the wild-type is signifi-
cantly larger than for the mutant (Figure 4; Table 1; and
the Supplemental Data). Such differences could arise
from the additional degrees of freedom lent to the wild-
type structure by the OG domain, as opposed to the
mutant, in which the two lobes are more confined. The het-
erogeneity of sizes results from two main variables: the
different orientations of the protein on the surface and
different protein conformations. As the mutant contains
no OG domain, it has a reduced conformational heteroge-
neity, meaning that the spread of values stems mainly from
different orientations on the surface.
The effect of the OG domain on protein flexibility is
clearly observed in Figure 4E, which reports measure-
ments of lobe-to-lobe distances. The spread of distances
ranges from 55 to 85 A˚ and can be divided into two sub-
populations. Remarkably, these results support the exis-
tence of multiple enzyme conformations mediated by the
flexible molecular nature of the OG domain. Figure 4F
presents some possible models of various protein confor-
mations based on the derived lobe-to-lobe distances. The
lobe-to-lobe distances were allowed to vary within one
standard deviation (9.5 A˚). The various OG domain confor-
mations presented in Figure 4F were calculated by using
the structural modeling program RAPPER (DePristo
et al., 2003a, 2003b).
The protein flexibility of pro-MMP-9, detected by this
molecular analysis, provides molecular insights, to our
knowledge not previously reported, into the overall struc-
ture and molecular character of the enzyme, highlighting
the structure-function uniqueness of pro-MMP-9 com-
pared to other members of the MMP family, including ge-
latinase A/MMP-2 (Morgunova et al., 1999). For instance,6, October 2007 ª2007 Elsevier Ltd All rights reserved 1231
Figure 3. AFM Images of Wild-Type and
Mutated Pro-MMP-9
(A–F) Glutaraldehyde served as a covalent
linker between the amine on the surface to
the protein. All scans employed a spike tip.
(A–C) Semidry mode scans of wild-type pro-
MMP-9. (D–F) Semidry mode scan of the
pro-MMP-9DOG mutant. (A) and (D) are two-
dimensional (plan-view) representations. (B)
and (E) are three-dimensional representations.
(C) and (F) are XZ cross-sections along the
dashed line shown in (A) and (D). Note the
expected reduction in protein length upon
deletion of the OG domain. For sample prepa-
ration and imaging conditions, see the text.
The height scale is indicated by the bar to the
right, in which the z axis ranges from 0 to 50
A˚ (dark to light).
Structure
Structural Model of Full-Length Pro-MMP-9in collagenase-1/MMP-1, the flexibility of a much shorter
linker region is further constrained by interactions between
the hemopexin domain and the prodomain (Lauer-Fields
et al., 2002). Similarly, in MMP-2, the second blade of the
hemopexin domain is linked to the fibronectin domain
through a hydrogen bond (Morgunova et al., 1999).
The Role of Protein Domain Flexibility in the
Enzymatic Function of Pro-MMP-9
MMP-9 is a secreted enzyme, and it is not clear how it is
targeted to the right location and how its activity is
controlled in the pericellular space (Fridman et al., 2003).
Specifically, it is not clear what the roles of the various do-
mains are in mediating effective protein-substrate and
protein-protein interactions during catalysis. The full-
length structural model of pro-MMP-9 reported here intro-
duces insights into the structure of this enzyme and into
its apparent domain flexibility. In particular, the reported
results raise the possibility that the terminal domain sepa-
ration and the observed protein flexibility in MMP-9 are
required to mediate its function.
The contribution of the OG domain was postulated in
earlier work to be a spacer moiety that allows for indepen-
dent movement of the terminal domains (Overall, 2002;
Rudd et al., 1999; Van den Steen et al., 2006). Interest-1232 Structure 15, 1227–1236, October 2007 ª2007 Elsevier Ltdingly, a bioinformatics ‘‘BLAST’’ search (Altschul et al.,
1997; Schaffer et al., 2001) of all of the available databases
revealed that the OG domain in pro-MMP-9 is homolo-
gous to similar disordered domains in a number of cell
surface-associated and ECM-binding proteins (see Table
S1). Remarkably, close structural homology was found
between the OG linker and the overall domain organiza-
tion of pro-MMP-9 and the fungi cellulase (Receveur
et al., 2002; von Ossowski et al., 2005), for which the
role of the linker in cellulase was proposed to mediate
protein-cellulose binding and enzyme migration in intact
matrices. This suggests that pro-MMP-9 mediates its
biological function and enzymatic activities by cell surface
association and/or interactions with solid substrates
(e.g., ECM).
Recently, Owen et al. (2003) described TIMP-1-resis-
tant MMP-9 activity at the cell surface of neutrophils.
One way to achieve tethering of the MMP-9 hemopexin
domain to the cell might be through interactions of the
MT6-MMP/TIMP-1 complex at the cell surface. Our data
suggest that OG domain flexibility allows the N terminus
of MMP-9 to access complex substrate networks (e.g.,
collagen-like molecules) in the pericellular environment.
Stabilization of such protein-substrate interactions may
be achieved by nonspecific protein-protein interactionsAll rights reserved
Figure 4. Size Distribution Histograms of
the Wild-Type and Pro-MMP-9DOG as
Measured by AFM
(A–F) The y axis of all histograms is the normal-
ized frequency obtained by dividing the counts
by the total population. The left panel repre-
sents wild-type pro-MMP-9, and the right
panel represents pro-MMP-9DOG. (A) and (B)
Height distribution. (C) and (D) Width distribu-
tion. The width values were corrected as de-
scribed in the Experimental Procedures. (E)
Lobe-to lobe distribution of wild-type pro-
MMP-9. The separation between lobes in
pro-MMP-9DOG could not be resolved. (F)
Modeling conformational states of pro-MMP-
9. A standard deviation of 9.5 A˚, as calculated
according to the lobe-to-lobe AFM data, was
subtracted or added to the interdomain sepa-
ration of the averaged structure obtained by
SAXS structural reconstruction. The N- and
C-terminal domains (Cha et al., 2002; Elkins
et al., 2002) are represented by a blue and
red cartoon, respectively. The OG domain
was reconstructed by using RAPPER (DePristo
et al., 2003a, 2003b) and is represented by
a green Ca trace.
Structure
Structural Model of Full-Length Pro-MMP-9mediated by the proline-rich sequences (Williamson,
1994) residing in the MMP-9 OG domain. In contrast, the
hemopexin domain and the fibronectin domain in pro-Table 1. Statistical Analysis of Sizes Obtained by AFM
Wild-Type Pro-MMP-9DOG
Height 34 (7.5) 22 (2.9)
Width 190 (33) 130 (13)
Lobe-to-lobe 78 (9.5) N/A
The most probable values are reported, since the presence of
two subpopulations may impose a bias on the mean value.
Standard deviation is reported in parentheses. The values
correspond to the wild type pro-MMP-9 (n = 90) and to the
pro-MMP-9DOG mutant (n = 120). Lobe-to-lobe distances
were measured between the peaks in the XZ cross-section.
Values were extracted only if the orientation of the protein
on the surface allowed for identification of two distinct do-
mains (n = 83). The separation between lobes in pro-MMP-
9DOG could not be distinguished. All values are given in ang-
stroms. It is noteworthy that the calculated axial ratio obtained
from the most probable height/width values, which represent
the ratio between the vertical length and the width of the
molecule, is 1:5.6, which is in good agreement with the axial
ratio obtained by AUC.
Structure 15, 1227–123MMP-9 were shown to stoichiometrically bind substrates
with great affinity (Collier et al., 1992; Roeb et al., 2002).
Importantly, correct interaction with TIMP-1, LRP-1,
and megalin requires OG domain involvement to achieve
proper orientation of the hemopexin and catalytic do-
mains (Van den Steen et al., 2006). The OG-deleted mu-
tant showed decreased affinity to these molecules, sug-
gesting that the OG domain is essential for regulating
the bioavailability of active MMP-9. Although our single-
molecule imaging results indicate that the spacing be-
tween the terminal domains is not constant, the quasi-
globular shape of the OG domain, as obtained by SAXS
model reconstruction, ensures minimal separation be-
tween the two domains, allowing for binding of regulators
to the C-terminal domain without steric hindrance from the
N-terminal catalytic domain. Such domain flexibility is not
observed for MMP-2. This may explain why MMP-9 can
bind directly to LRP-1, while MMP-2 requires the forma-
tion of a precursor complex with TIMP-2 (Emonard et al.,
2004) or with thrombospondin (Yang et al., 2001) to
achieve effective binding to LRP-1.
Conclusions
To our knowledge, this work represents the first experi-
mental structural model determination of full-length human6, October 2007 ª2007 Elsevier Ltd All rights reserved 1233
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Structural Model of Full-Length Pro-MMP-9pro-MMP-9 revealed by the combination of structural
analyses. A combination of single-molecule imaging and
SAXS was utilized to derive a comprehensive molecular
model providing structural and dynamic insights into this
important enzyme. Remarkably, our results demonstrate
the presence of a flexible and unstructured OG domain
bridging the catalytic enzyme core and the hemopexin
domain. This structure endows pro-MMP-9 with unique
domain architecture relative to other family members.
Such structural exclusiveness may be utilized for the de-
sign of isoform-selective inhibitors for MMP-9. The design
of regulators for MMP-9 may be targeted at restricting its
domain flexibility, whichmay block its pathological activity
in specific disease states.EXPERIMENTAL PROCEDURES
Recombinant pro-MMP-9 was expressed by infection of Sf9 insect
cells with a baculovirus carrying the cDNA of human pro-MMP-9
(Van den Steen et al., 2006). Liter quantities of cell culture fluids
were centrifuged, filtered, and purified to homogeneity by using gela-
tin-Sepharose chromatography (Masure et al., 1991). Thematerial was
extensively dialyzed in 100 mM Tris (pH 7.4), 100 mM NaCl, 10 mM
CaCl2 (buffer C) before further processing, and 20 mg was used in
the present study. A mutant lacking the OG domain (MMP-9DOG)
was prepared in a similar manner (Van den Steen et al., 2006).
Small-Angle X-Ray Scattering
Small-angle X-ray scattering (SAXS) experiments in solution were per-
formed at station 2.1 (Towns-Andrews et al., 1989) of the Synchrotron
Radiation Source, Daresbury Laboratory, UK, by following standard
procedures. The protein solution was centrifuged for 5 min at 13,000
3 g before being measured at 4C. Scattering curves were collected
with a two-dimensional multiwire proportional counter, at sample-to-
detector distances of 1 m (7 mg/ml, 100 ml) and 4.25 m (0.8, 1.6, 2.5
mg/ml, 100 ml), at a wavelength (l) of 1.54 A˚, covering the momentum
transfer range of 0.008 < q < 0.78 A˚1 (q = 4psinq/l, where 2q is the
scattering angle). The data were collected in 30 successive 1 min
frames, and they were then normalized to the intensity of the incident
beam, radially integrated over a 60 sector, averaged over the frame
number, and normalized to the detector response. The scattering of
the buffer was then subtracted, and the low- and high-angle curves
were merged over the q range of 0.05–0.15 A˚1. Reproducibility of
the intensity as a function of time was evidence for lack of radiation
damage of the monomeric pro-MMP-9 sample, and this was further
verified by SDS-PAGE (see the Supplemental Data and Figure S3).
Both the forward scattering intensity, I(0), and the radius of gyration
(Rg) were evaluated with the program package PRIMUS (Konarev
et al., 2003) by using the Guinier approximation: I(q) =
I(0)exp(q2Rg2/3) for qRg < 1.3 (Guinier and Fournet, 1955). In addition,
we used the indirect Fourier-transform program GNOM (Svergun,
1992) on the entire scattering curve. GNOM also provides the distance
distribution function, p(r), of the particle and its maximum dimension
Dmax, defined as the point at which p(r) becomes zero. To determine
p(r), we assigned p(0) = 0 and p(Dmax) free, in the first instance, to
judge whether the chosen r interval was correct. Dmax was the lowest
value yielding the lowest positive p(Dmax). After fixing Dmax, p(0) and
p(Dmax) were fixed to zero. The data were then cut at the low- and
high-angle region until the p(r) functions converged.
The crystal structures of the two MMP-9 domains (N-terminal cata-
lytic domain and C-terminal hemopexin domain) were analyzed by us-
ing the program CRYSOL (Svergun et al., 1995) in order to calculate
their corresponding theoretical scattering curves. These were further
Fourier transformed to yield their theoretical pair distribution functions,
while the Dmax and Rg values were calculated. Ab initio modeling of the1234 Structure 15, 1227–1236, October 2007 ª2007 Elsevier LtdSAXS curves are described in detail in the Supplemental Data. Struc-
tural figures were made with PyMOL (DeLano, 2002).
To further confirm the accuracy of the model, its solution hydrody-
namic properties were calculated by using HYDROPRO (Garcia De
La Torre et al., 2000), and then compared to the experimental values.
The radius of shell minibeads was varied from 2.2 to 4.2 A˚ in six incre-
ments. The solvent density and viscosity and the protein partial spe-
cific volume were calculated by using SEDNTERP (Laue et al., 1992).
Sphere radii for the hydrodynamic shell model varied between 3.8
and 5.3 A˚. The radius of the dummy residues (DRs) in the SAXS model
is 3.8 A˚. However, the actual dimension of the shell model is slightly
larger due to protein hydration, yet the extent of enlargement is difficult
to determine (Garcia De La Torre et al., 2000). It was previously sug-
gested that increasing the DRs’ radii by 1.5 A˚ would take into account
hydration reliably (Ackerman et al., 2003).Atomic Force Microscopy Imaging
Imaging was performed by using a multimode atomic force micro-
scope (MMAFM Veeco/Digital Instruments, Santa Barbara, CA, USA)
equipped with an E-scanner, with a maximum scan range of 14 3 14
mm2. Samples were imaged in air or in buffer by using Tapping
Mode. To obtain samples free of artifacts from spurious adsorbates,
mainly salt deposition, an aggressive rinsing procedure was required.
By using the amine-modified silane surfaces and the crosslinking pro-
cedure, it was possible to prepare surfaces that removed nearly all of
the background (as determined by blank runs), while maintaining
a significant surface concentration of the protein.
In order to minimize the amount of force applied, the amplitude set
point was adjusted to the maximum value that gave a stable trace.
High-resolution images of biological samples in air were obtained by
using ‘‘spike’’ tips-DP14 ‘‘HI-RESTM’’ probes from Mikromasch (Esto-
nia). These probes have a resonant frequency of 160 kHz, a force
constant of 5 N/m, and a rated radius of curvature of 2 nm or less,
but they are only suitable for measurements on surfaces with an rms
roughness of less then 20 nm due to the presence of additional
‘‘spikes’’ that could cause multiple contacts on a rough surface.
DNP-S probes (Veeco) with a nominal radius of 20 nm were used for
the liquid measurements, which were performed in the standard
MMAFM liquid cell. The sizes of the protein molecules were deter-
mined from cross-sectional analysis. The width values were then cor-
rected for broadening by the tip, by subtracting the tip envelope as
observed from a typical high-resolution SEM image.Supplemental Data
Supplemental Data include complete details of experimental condi-
tions, sample preparation, and data analysis and are available at
http://www.structure.org/cgi/content/full/15/10/1227/DC1/.ACKNOWLEDGMENTS
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